The Rate and Predictors of Vaginal Bleeding Among Women With Placenta Previa
Launched by ASSIUT UNIVERSITY · Dec 8, 2022
Trial Information
Current as of February 05, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Pregnant women ≥ 28 weeks.
- • Diagnosed to have placenta previa by ultrasound
- Exclusion Criteria:
- • Women with complicated pregnancies (e.g. preeclampsia, diabetes mellitus and cardiac, renal, antiphospholipid syndrome).
- • Women with premature rupture of membrane.
- • Women who will refuse to participate.
Trial Officials
Kamal M Zahran, professor
Study Chair
department of obstetrics and gynecology, faculty of medicine, Assuit University, Egypt
Mohamed K Ali, doctor
Study Director
department of obstetrics and gynecology, faculty of medicine, Assuit University, Egypt
Mohamed M Abd-allah, doctor
Study Director
department of obstetrics and gynecology, faculty of medicine, Assuit University, Egypt
Ismael O Ali, resident
Principal Investigator
department of obstetrics and gynecology, faculty of medicine, Assuit University, Egypt
About Assiut University
Assiut University, a prominent academic institution located in Egypt, is dedicated to advancing medical research and clinical trials that enhance healthcare outcomes. With a strong emphasis on innovation and collaboration, the university engages in a wide array of clinical studies across various disciplines, aiming to contribute valuable insights into disease prevention, diagnosis, and treatment. Assiut University's commitment to ethical research practices and rigorous scientific methodology ensures the integrity and reliability of its clinical trials, ultimately benefiting both the local community and the global medical landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials